Clinical Trials Browser

Triple Negative Breast Neoplasms

Adenocarcinoma Of Esophagus, Neoplasms

Advanced Solid Tumor Cancer

Breast Neoplasms, Neoplasm Metastasis

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Endometrial Neoplasms

Gastroesophageal Adenocarcinoma

Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Solid Tumor, Adult

Carcinoma, Non-Small-Cell Lung, Neoplasms

Hemangiosarcoma

Triple Negative Breast Neoplasms

Advanced Malignancies

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Digestive System Neoplasms

Ovarian Neoplasms

Neoplasm Metastasis, Peritoneal Neoplasms

Carcinoma, Squamous Cell, Neoplasms, Squamous Cell

Carcinoma, Renal Cell, Colorectal Neoplasms

Ovarian Neoplasms

Breast Neoplasms

Multiple Myeloma, Triple Negative Breast Neoplasms

Esophageal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body

Carcinoma, Non-Small-Cell Lung

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC

PIKASSO-01

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients

Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies

Study of INCB123667 in Subjects With Advanced Solid Tumors

Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

MK-3475A-C18

NOVOCURE

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer